12.12.25
10 min. Read

ACCESS exuberance, hints, clues and uncertainties

Issue 356
Welcome back to E&O: a paying subscribers-only weekly newsletter focused on three areas of health tech: FDA-regulated software devices, digital health as an employee benefit, and national virtual clinics.

Exits & Outcomes Newsletter


Was this forwarded to you? Click this link for more info on how to become a paying subscriber.

ACCESS Model exuberance, hints, uncertainties

You can't open a new browser tab right now without stumbling on

Sign-up for the newsletter for access.

It's a good one, too.

This article is for Exits & Outcomes subscribers only. Subscribe now to get the weekly newsletter. Enter your email below to subscribe today!

×

Six years of Oura’s financials: Revenue, profits, marketing spend and more
5.22.26
4 min. Read
ACCESS Model’s first dropout? Plus: A few new participants
5.08.26
6 min. Read
Are these Utah’s next four AI experiments? Plus: More on the Utah Pharmacy Board’s questions about Doctronic
4.17.26
9 min. Read
Emails show how Doctronic’s AI pilot blindsided Utah’s Medical Board
4.10.26
13 min. Read
Quiet funding rounds. Plus: Digital health-related clinical trial round-ups
3.20.26
5 min. Read
Details: Vida Health’s brief GLP-1 rollout in Mass. Plus: CMS says Freespira not DME
3.13.26
7 min. Read
AI billing codes for 5-min visits? Cityblock $1.5B ARR.
2.27.26
8 min. Read
K Health shuts down DTC clinic. Big employer customer wins, losses
2.20.26
6 min. Read
ACCESS Model’s shockingly low payments. DMHT Rx count.
2.13.26
7 min. Read
Spring Health’s stealthy AI venture, quiet AI acquihire, DTC plans
2.06.26
6 min. Read
  • First
  • Previous
  • 1 of 43
  • Next
  • Last